Scholarly article on (3aS,4S,7aS)-1-(Octahydro-inden-4-yl)-methanol 67566-59-0 from Journal of the American Chemical Society p. 4321 - 4322

DOI: 10.1021/ja00481a062

Source and publish data:

Journal of the American Chemical Society p. 4321 - 4322 (1978)

Update date:2022-08-05

Topics:

Authors:

Wender,P.A.

Lechleiter,J.C.

Read Full Text PDF DownLoad Join now for total 90,000,000 free articles

Article abstract of DOI:10.1021/ja00481a062

Full text of DOI:10.1021/ja00481a062

Products guided by the article

Product name:(3aS,4S,7aS)-1-(Octahydro-inden-4-yl)-methanol

Cas No:67566-59-0

R&D Labs maybe for 67566-59-0

Jinan Hongfangde Pharmatech Co.LTD

Contact:0531-88870908

Address:F Bldg,750#,Shunhua Rd,New&High-tech Zone,Jinan,Shandong,China 250101
Changzhou Sunlight Pharmaceutical Co., Ltd.

Contact:+86-519-83131668;83139028;83138042;83137041

Address:JiuliStreet, Benniu Town Changzhou City, Jiangsu Province
Chengda Pharmaceuticals Co., Ltd.

Contact:+86-573-84601188

Address:hengshan Road 5# in Jiashan, zhejiang
Winchem Industrial Co. Ltd.(expird)

Contact:86-574-83851061 86-574-87083208

Address:Room 905, No.3 Building,East Business Center, 456 Xingning Road, Ningbo City,China
Chongqing Shuangfeng Chemical Co.,Ltd

Contact:+86-23-49850156

Address:No.663,xuanhua Rd,yongchuan,chongqing,China

Relevant to this article

General strategy for the preparation of membrane permeable fluorogenic peptide ester conjugates for in vivo studies of ester prodrug stability

Doi:10.1016/j.bmc.2003.11.016
(2004)
Doi:10.1246/cl.1978.785
(1978)
Development and Application of Subtype-Selective Fluorescent Antagonists for the Study of the Human Adenosine A₁Receptor in Living Cells

Doi:10.1021/acs.jmedchem.0c02067
(2021)
Doi:10.1002/hlca.19500330518
(1950)
Dimeric naphthoquinones, VI. Synthesis of 3,3'-biplumbagin and related 3,3'-dimethyl-2,2'-bi-1,4-naphthoquinones by C-methylation with diazomethane

Doi:10.1002/jlac.198319830215
(1983)
Novel 3-aryl-5-substituted-coumarin analogues: Synthesis and bioactivity profile

Doi:10.1002/ddr.21639
(2020)

Article Doi

DOI: 10.1021/ja00481a062